City

Condition

ATTR Amyloidosis With Cardiomyopathy (1)

Transthyretin-mediated Amyloidosis With Cardiomyopathy (1)

Overall Status

Available (1)

Sign in for free

Phase

Sponsor

Alnylam Pharmaceuticals (1)

Collaborator

Intervention

patisiran (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Expanded Access (1)

attr amyloidosis with cardiomyopathy

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Transthyretin-mediated Amyloidosis With Cardiomyopathy, ATTR Amyloidosis With Cardiomyopathy Trial (Patisiran)

Available

Transthyretin-mediated Amyloidosis With Cardiomyopathy
ATTR Amyloidosis With Cardiomyopathy

Patisiran

(no location specified)

Aug 17, 2022